.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The Multi-Omics for Mothers and Infants (MOMI) Consortium represents a transformative global initiative aimed at decoding the biological mechanisms behind adverse pregnancy outcomes. These complications, which include preterm birth, preeclampsia, and stillbirth, remain a significant challenge for maternal health systems worldwide. Specifically, the burden of these outcomes is disproportionately high in low- and middle-income countries (LMICs). By combining diverse data sources, the consortium seeks to identify critical biological signatures that could lead to better diagnostic tools. This massive undertaking involves a cohort of over 24,000 pregnant women from various international sites.
To understand the multifactorial drivers of these conditions, researchers employ an integrative multi-omics approach. This strategy encompasses genomics, metabolomics, proteomics, and nutrient testing. Consequently, scientists can map the complex interactions between genetics and the environment. Furthermore, the consortium focuses on site-specific signatures, acknowledging that local factors often influence health outcomes. Therefore, the data collected from sites in Bangladesh, Pakistan, Tanzania, and Zambia provides a rich tapestry of information. These efforts allow clinicians to move beyond traditional risk factors toward molecular-based precision medicine.
A vital component of this global network is the Interdisciplinary Group for Advanced Research on Birth Outcomes (GARBH-Ini), a DBT India Initiative. This partnership highlights India's leading role in addressing maternal health challenges through high-quality cohort studies. Additionally, five analytical partners and three bioinformatics teams support the consortium’s rigorous data harmonisation. As a result, the project ensures that findings are robust and applicable across different populations. Notably, the study protocol emphasizes the importance of paired socioeconomic and clinical data to provide a holistic view of pregnancy health.
The primary goal of the MOMI study is to translate molecular findings into enhanced clinical care. By identifying early biomarkers, healthcare providers may soon implement novel therapeutic interventions. Moreover, the initiative paves the way for developing affordable diagnostic tools tailored for resource-limited settings. Ultimately, the consortium aims to reduce maternal and neonatal morbidity by addressing the root causes of pregnancy complications. This research fosters a deeper understanding of placental health and its impact on the long-term well-being of both mothers and infants.
The consortium aims to define the biological mechanisms associated with preterm birth, small for gestational age, preeclampsia, and stillbirth. It focuses on identifying omics-based signatures to improve diagnostic and therapeutic tools in LMICs.
The GARBH-Ini, supported by the DBT India Initiative, provides a specialized cohort and clinical data. This collaboration ensures that the diverse biological and socioeconomic landscape of India is represented in global maternal health research.
Researchers are using an integrative approach that includes genomics, proteomics, metabolomics, and nutrient testing. These layers of data help identify molecular drivers that contribute to different pregnancy outcomes.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The MOMI Consortium integrates multi-omics to identify biological signatures for adverse pregnancy outcomes like preterm birth and stillbirth in LMICs....
3 months ago
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
